Lindsay Ekiss
Nurse Practitioner · Eagle River, AKNPI 1902325558
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $654 of the $755 with a category attached, or 86.6%. 12 manufacturers reported payments, led by AbbVie at 30.2% of the total. Reporting peaked in 2024 at $586 and has fallen 78.9% since, to $123 in 2025.
Across 28 payments — averaging $26.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$228
- Amgen$147
- Johnson & Johnson$140
- UCB, Inc.$58
- Pfizer$46
- AstraZeneca$24
- plus $113 from 6 others
What the payments were for
- Food & beverage$65487%
- Education$10113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $228 |
| Amgen | 6 | $147 |
| Johnson & Johnson | 5 | $140 |
| UCB, Inc. | 3 | $58 |
| Pfizer | 2 | $46 |
| AstraZeneca | 1 | $24 |
| Sanofi | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Genentech USA, Inc. | 1 | $19 |
| Sobi, Inc | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
How this compares
$755 in reported general payments places this provider in the 85th percentile of 212 nurse practitioner providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 24 | $164,411 |
| Hydroxychloroquine Sulfate | 16 | $2,034 |
| Celecoxib | 14 | $492 |
| MethotrexateMethotrexate Sodium | 20 | $446 |
| Prednisone | 71 | $300 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Eagle River
- Thomas LalorEagle River$2K
- Lennett LerchEagle River$897
- Andrea LewisEagle River$735
- Tamara SimpsonWasilla$18K
- Charlotte NelsonWasilla$6K
- Jessica BrayPalmer$5K
- Amanda EnosPalmer$5K
- Ellen LentzWasilla$5K
- Wezzie MunthaliAnchorage$4K
- Lily GeorgeAnchorage$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.